|
1
|
Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
|
Int J Urol
|
2014
|
2.68
|
|
2
|
Vesicoenteric fistula created by ingested foreign body in Meckel's diverticulum.
|
J Urol
|
2002
|
0.94
|
|
3
|
A single injection of lidocaine as local anesthesia for ultrasound guided needle biopsy of the prostate.
|
J Urol
|
2002
|
0.94
|
|
4
|
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study.
|
Urol Int
|
2010
|
0.89
|
|
5
|
Paraganglioma of the prostate in a young adult.
|
Urology
|
2005
|
0.84
|
|
6
|
Bladder cell culture on small intestinal submucosa as bioscaffold: experimental study on engineered urothelial grafts.
|
Eur Urol
|
2004
|
0.83
|
|
7
|
A simple mathematical approach to calculate blood loss in radical prostatectomy.
|
Urol Int
|
2004
|
0.82
|
|
8
|
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
|
Urol Oncol
|
2009
|
0.80
|
|
9
|
Bladder cancer.
|
Crit Rev Oncol Hematol
|
2002
|
0.80
|
|
10
|
TC incidence increasing: spread the word.
|
Eur Urol
|
2006
|
0.79
|
|
11
|
Age is predictive of immediate postoperative urinary continence after radical retropubic prostatectomy.
|
Urol Int
|
2013
|
0.79
|
|
12
|
Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability.
|
Anticancer Res
|
2005
|
0.79
|
|
13
|
Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77.
|
Eur Urol
|
2006
|
0.78
|
|
14
|
Retropubic nerve and seminal sparing radical prostatectomy for recurrent bladder neck-prostatic urethra strictures.
|
Arch Ital Urol Androl
|
2005
|
0.78
|
|
15
|
High-risk prostate cancer is worth further risk stratification.
|
Eur Urol
|
2007
|
0.77
|
|
16
|
[Nephron-sparing surgery. Reproducibility of results, personal cases, and comparison with the international literature].
|
Arch Ital Urol Androl
|
2002
|
0.77
|
|
17
|
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry.
|
Urol Oncol
|
2011
|
0.77
|
|
18
|
Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsy.
|
Int J Biol Markers
|
2010
|
0.76
|
|
19
|
Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder.
|
Urology
|
2005
|
0.75
|
|
20
|
Active surveillance in young patients with prostate cancer: the unanswered question.
|
J Clin Oncol
|
2010
|
0.75
|
|
21
|
Cancer detection with TRUS-guided 10-core biopsy of the prostate. an institutional assessment at the first, repeated and surgical specimen biopsy.
|
Arch Ital Urol Androl
|
2006
|
0.75
|
|
22
|
For wider acceptance of radical cystectomy and extended pelvic lymphadenectomy.
|
Eur Urol
|
2010
|
0.75
|
|
23
|
Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
|
J Urol
|
2005
|
0.75
|
|
24
|
Editorial comment on: long-term rates of undetectable psa with initial observation and delayed salvage radiotherapy after radical prostatectomy.
|
Eur Urol
|
2008
|
0.75
|
|
25
|
Feeding hungry patients, even those well nourished.
|
Eur Urol
|
2012
|
0.75
|
|
26
|
Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
|
Int J Urol
|
2014
|
0.75
|
|
27
|
Re: Vincent Cloutier, Umberto Capitanio, Laurent Zini, et al. Thirty-day mortality after nephrectomy: clinical implications for informed consent. Eur urol 2009;56:998-1005.
|
Eur Urol
|
2009
|
0.75
|
|
28
|
Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.
|
Adv Urol
|
2012
|
0.75
|
|
29
|
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
|
Cancer Prev Res (Phila)
|
2009
|
0.75
|
|
30
|
A case of spontaneous rupture of the renal pelvis initially misdiagnosed as a ruptured aneurysm of the abdominal aorta.
|
J Emerg Med
|
2013
|
0.75
|
|
31
|
The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
|
Urol Int
|
2013
|
0.75
|
|
32
|
Short-time ureteral catheterization after operative ureteroscopic lithotripsy: an alternative to stent versus no stent evaluated in a retrospective study.
|
Arch Ital Urol Androl
|
2009
|
0.75
|
|
33
|
Prostatic metastases from testicular nonseminomatous germ cell cancer: two case reports and a review of the literature.
|
Tumori
|
2013
|
0.75
|
|
34
|
Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.
|
Anticancer Res
|
2007
|
0.75
|
|
35
|
[Focal therapy in urology: kidney cancer].
|
Urologia
|
2013
|
0.75
|